Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma
Clinical trial NCT02899195 · COMPLETED
Trial details
- NCT number
- NCT02899195
- Sponsor
- PrECOG, LLC.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2020-02-16
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.